RARECast

A podcast by RARECast - Thursdays

Thursdays

Categories:

516 Episodes

  1. Addressing the Challenges of R&D for Rare Cancer Therapies

    Published: 5/2/2018
  2. Learning to Communicate and Collaborate as a Patient Advocate

    Published: 4/25/2018
  3. Seeking Answers for Undiagnosed Patients

    Published: 4/18/2018
  4. When "Undiagnosed" Is Your Diagnosis

    Published: 4/11/2018
  5. The Decision to Get Tested for Huntington's Disease and How It Changed Seth Rotberg's Life

    Published: 4/4/2018
  6. Nonprofit Sees Need in Developing Gene Therapies for Inherited Eye Disesases

    Published: 3/29/2018
  7. Casting a Wider Net for Genetic Diseases

    Published: 3/21/2018
  8. Corbus Seeks to Quiet the Immune System in Chronic Conditions

    Published: 3/14/2018
  9. Addressing the Challenges of Rare Disease Drug Development

    Published: 3/7/2018
  10. Giving Voice to Patients at the FDA

    Published: 2/28/2018
  11. Finding a Rare Friend

    Published: 2/21/2018
  12. Why a Sports Physical May Trigger a Doctor to Think About a Rare Diagnosis

    Published: 2/14/2018
  13. UPenn's Orphan Disease Center Takes a Rare Approach

    Published: 2/7/2018
  14. How Patients Can Accelerate Translational Research in Rare Disease

    Published: 1/31/2018
  15. Notre Dame Center Leverages Commonalities of Rare and Neglected Diseases

    Published: 1/24/2018
  16. GalXC Quest: Dicerna Bets on Its Unqiue Approach to RNAi

    Published: 1/17/2018
  17. Pharnext Takes a Unique Twist on Repurposing Drugs for Rare Diseases

    Published: 1/10/2018
  18. uniQure Seeks to Find Elusive Market Success with Hemophilia B Gene Therapy

    Published: 1/3/2018
  19. Savara Advances Pipeline of Inhaled Therapeutics for Rare Lung Diseases

    Published: 12/27/2017
  20. Why the Microbiome May Provide a Novel Approach to Treating Certain Rare Diseases

    Published: 12/20/2017

18 / 26

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.